BroadOak Invests in Microsize (Lonza's North American Micronization Business)

July 1, 2022

BroadOak Capital Partners led an investor-backed launch of Microsize after acquiring Lonza’s North American micronization business in Quakertown, Pennsylvania. The newly independent CDMO — operating three facilities and focused on micronization and particle-size control for APIs and excipients — will be run by industry veterans including Chairman Derek Hennecke and CEO TJ Higley to expand US-based API solubility and bioavailability enhancement capabilities.

Buyers
BroadOak Capital Partners, Investor group of industry veterans (including Derek Hennecke and TJ Higley)
Targets
Microsize
Sellers
Lonza
Industry
Pharmaceuticals
Location
Pennsylvania, United States
Transaction Type
Divestiture

Explore More

Related articles

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.

Find buyers like these →